
TREATING
CENTRAL SLEEP APNEA
TREATING
CENTRAL SLEEP APNEA
September 20, 2022
Expanded insurance coverage now available in Utah, Idaho and Nevada
August 5, 2021
The new remedē EL-X model delivers extended longevity, reduced size, and an enhanced suite of diagnostics
May 17, 2021
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the peer-reviewed journal Nature and Science of Sleep has published five-year results from the remedē System Post Approval Study.
April 12, 2021
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has acquired Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).